RE:I will not be supporting alleyesonme...I'm just going to have a little bit of fun. VIVO was an acquistion by LABS, call it the middle towards the down. What if LABS issued more shares, as an example only, to someone like Pfizer so that Pfizer makes LABS part of them, call it the top towards the middle. M&A activity is a two way street so to say. Would you object to that type of M&A activity if and when LABS approached by a much, much, bigger fish?
Just be patient, Pidduck said they have a plan NOT to RAISE cash in the near term but to GENERATE cash in the near term. In the business sense definition, raise vs generate are not at all equal. Raise is done by going to the well and issuing more shares as one mode. Generating cash is done through your ongoing operations.
We have the FDA approval on the NDA, we are waiting merely for the drug monograph which imho, at this time, might just be the catalyst to generate cash in the near term.
Don't even look at the stock price, stay focused on the facts that have been disclosed and don't get impatient like me at times. Fondle the fact of the drug monograph and all my concerns melt away.
Peace and tranquility.